Interstitial lung disease on the acute take for the non-respiratory physician

被引：2

作者：

Yioe, Veronica ^{[1
]}

Phillips, Gerrard ^{[2
,3
]}

Spencer, Lisa G. ^{[1
]}

机构：

[1] Aintree Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England

[2] Federat Royal Coll Phys, London, England

[3] Dorset Cty Hosp, Dorchester, England

来源：

CLINICAL MEDICINE | 2021年 / 21卷 / 06期

关键词：

interstitial lung disease; acute exacerbation of ILD; antifibrotic drugs; immunosuppression; acute take; IDIOPATHIC PULMONARY-FIBROSIS; ACUTE EXACERBATION;

D O I：

10.7861/clinmed.2021-0694

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Interstitial lung diseases (ILDs) are a heterogeneous group of diseases characterised by varying degrees of fibrotic and/ or inflammatory abnormalities of the lung parenchyma. Management of ILD is often challenging for non-respiratory physicians. We discuss the respiratory assessment and management of patients with ILD presenting with acute breathlessness on the acute take, including acute exacerbations of ILD.

引用

页码：E584 / E590

页数：7

共 50 条

[31] Acute on chronic respiratory failure in interstitial pneumonias
Westhoff, M.
MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, 2015, 110 (03) : 188 - 196
[32] Bridge or Abyss: Extracorporeal Membrane Oxygenation for Acute Respiratory Failure in Interstitial Lung Disease
Moerer, Onnen
Quintel, Michael
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193 (05) : 474 - 476
[33] Acute exacerbations of interstitial lung disease: lessons from idiopathic pulmonary fibrosis
Spagnolo, Paolo
Wuyts, Wim
CURRENT OPINION IN PULMONARY MEDICINE, 2017, 23 (05) : 411 - 417
[34] Associations between Comorbidities and Acute Exacerbation of Interstitial Lung Disease after Primary Lung Cancer Surgery
Kato, Takahide
Miyoshi, Seigo
Hamada, Chizuru
Sano, Yoshifumi
Nogami, Naoyuki
Yamaguchi, Osamu
Hamaguchi, Naohiko
ACTA MEDICA OKAYAMA, 2023, 77 (03) : 301 - 309
[35] Year in review 2014: Interstitial lung disease, physiology, sleep and ventilation, acute respiratory distress syndrome, cystic fibrosis, bronchiectasis and rare lung disease
Maher, Toby M.
Piper, Amanda
Song, Yuanlin
Restrepo, Marcos I.
Eves, Neil D.
RESPIROLOGY, 2015, 20 (05) : 834 - 845
[36] Acute Respiratory Deterioration in Rheumatoid Arthritis-Associated Interstitial Lung Disease A Single-Center Study
Kwon, Byoung Soo
Lee, Ho Young
Choe, Jooae
Chae, Eun Jin
Hong, Seokchan
Song, Jin Woo
CHEST, 2022, 162 (01) : 136 - 144
[37] Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer
Hamada, Shohei
Ichiyasu, Hidenori
Ikeda, Tokunori
Inaba, Megumi
Kashiwabara, Kosuke
Sadamatsu, Tomoki
Sato, Nahoko
Akaike, Kimitaka
Okabayashi, Hiroko
Saruwatari, Koichi
Tomita, Yusuke
Saeki, Sho
Hirata, Naomi
Yoshinaga, Takeshi
Fujii, Kazuhiko
BMC PULMONARY MEDICINE, 2019, 19 (1)
[38] Treatment of acute exacerbation in interstitial lung disease secondary to autoimmune rheumatic diseases: More questions than answers
Luppi, Fabrizio
Manfredi, Andreina
Faverio, Paola
Franco, Giovanni
Salvarani, Carlo
Bendstrup, Elisabeth
Sebastiani, Marco
AUTOIMMUNITY REVIEWS, 2024, 23 (12)
[39] Lung transplantation for acute exacerbation of interstitial lung disease
Chizinga, Mwelwa
Machuca, Tiago N.
Shahmohammadi, Abbas
Patel, Divya C.
Innabi, Ayoub
Alzghoul, Bashar
Scheuble, Vanessa
Pipkin, Mauricio
Mehrad, Borna
Pelaez, Andres
Lin, Christine
Gomez-Manjarres, Diana
THORAX, 2022, 77 (04) : 364 - 369
[40] Causes of acute respiratory hospitalizations predict survival in fibrosing interstitial lung diseases
Salonen, Johanna
Vahanikkila, Hannu
Purokivi, Minna
Kaarteenaho, Riitta
PLOS ONE, 2020, 15 (11):

← 1 2 3 4 5 →